You get one chance to initiate a clinical trial. Botch the start-up and you’ll expend great effort correcting course and playing catch-up. The waste of money and time — commodities that are chronically scarce among the biotech and specialty pharma companies that comprise most of our customer base — can be devastating.
That’s why we created a department that consolidates all the expertise needed to get trials off on the right foot. The underlying goal is to simplify by doing a lot of advance work and by setting sponsors up for success with a single contact throughout the start-up process, from country/site identification and regulatory, IRB, and EC submissions to site activation.
That way, our customers can focus more on science and less on … everything else.